E-LIB Suche - Ergebnisse für: Engwall, Michael

1

Best practice considerations for nonclinical in vivo cardio..:

Rossman, Eric I. ; Wisialowski, Todd A. ; Vargas, Hugo M....
Journal of Pharmacological and Toxicological Methods. 123 (2023) - p. 107270 , 2023

Link: https://doi.org/10.1016/..

2

Evaluation of levocetirizine in beagle dog and cynomolgus m..:

Engwall, Michael J. ; Baublits, Joel ; Chandra, Fiona A....
Clinical and Translational Science. 16 (2022) 3 - p. 436-446 , 2022

Link: https://doi.org/10.1111/..

3

The in vivo QTc core assay: An evaluation of QTc variabilit..:

Baublits, Joel ; Vargas, Hugo M. ; Engwall, Michael J.
Journal of Pharmacological and Toxicological Methods. 109 (2021) - p. 107067 , 2021

Link: https://doi.org/10.1016/..

4

The Effects of Repeat-Dose Doxorubicin on Cardiovascular Fu..:

Engwall, Michael J. ; Everds, Nancy ; Turk, James R..
Frontiers in Cardiovascular Medicine. 8 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

5

Evaluation of moxifloxacin in canine and non‐human primate ..:

Chui, Ray W. ; Baublits, Joel ; Chandra, Fiona A....
Clinical and Translational Science. 14 (2021) 6 - p. 2379-2390 , 2021

Link: https://doi.org/10.1111/..

6

Corrigendum to "The in vivo QTc core assay: An evaluation o..:

Baublits, Joel ; Vargas, Hugo M. ; Engwall, Michael J.
Journal of Pharmacological and Toxicological Methods. 112 (2021) - p. 107104 , 2021

Link: https://doi.org/10.1016/..

7

Nonclinical cardiovascular safety evaluation of romosozumab..:

Turk, James R. ; Deaton, Aimee M. ; Yin, Jun...
Regulatory Toxicology and Pharmacology. 115 (2020) - p. 104697 , 2020

Link: https://doi.org/10.1016/..

8

Time for a Fully Integrated Nonclinical–Clinical Risk Asses..:

Vargas, Hugo M. ; Rolf, Michael G. ; Wisialowski, Todd A....
Clinical Pharmacology & Therapeutics. 109 (2020) 2 - p. 310-318 , 2020

Link: https://doi.org/10.1002/..

9

Clinical Implications and Translation of an Off-Target Phar..:

Amouzadeh, Hamid R. ; Dimery, Isaiah ; Werner, Jonathan...
Translational Oncology. 12 (2019) 10 - p. 1296-1304 , 2019

Link: https://doi.org/10.1016/..

10

Considerations for an In Vitro, Cell-Based Testing Platform..:

Guth, Brian D. ; Engwall, Michael ; Eldridge, Sandy...
Frontiers in Pharmacology. 10 (2019) - p. , 2019

Link: https://doi.org/10.3389/..

11

Leveraging machine learning for automated ECG and hemodynam..:

Baublits, Joel T. ; Barreda, Jose ; Engwall, Michael J...
Journal of Pharmacological and Toxicological Methods. 99 (2019) - p. 106595 , 2019

Link: https://doi.org/10.1016/..

12

Baseline characterization of three canine cardiovascular mo..:

Baublits, Joel T. ; Sutherland, Weston ; Escamilla, Maximiliano...
Journal of Pharmacological and Toxicological Methods. 99 (2019) - p. 106595 , 2019

Link: https://doi.org/10.1016/..

13

Considerations for an In Vitro, Cell-Based Testing Platform..:

Ribeiro, Alexandre J. S. ; Guth, Brian D. ; Engwall, Michael...
Frontiers in Pharmacology. 10 (2019) - p. , 2019

Link: https://doi.org/10.3389/..

14

The evaluation of endpoint variability and implications for..:

Chiang, Alan Y. ; Guth, Brian D. ; Pugsley, Michael K....
Journal of Pharmacological and Toxicological Methods. 92 (2018) - p. 43-51 , 2018

Link: https://doi.org/10.1016/..

15

NOAELs or not in safety pharmacology—An industry survey:

Andersen, Ninette ; Authier, Simon ; Bass, Alan...
Journal of Pharmacological and Toxicological Methods. 93 (2018) - p. 172-173 , 2018

Link: https://doi.org/10.1016/..